Last updated on March 2017

Study of FPA008 in Combination With Nivolumab in Patients With Selected Advanced Cancers


Brief description of study

This is a phase 1a/b single-arm, open-label study to evaluate safety, tolerability, PK, and clinical benefit of FPA008 in combination with nivolumab in patients with selected advanced cancers.

Clinical Study Identifier: NCT02526017

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Michael S Gordon, MD

Scottsdale Healthcare Hospitals DBA Honor Health
Scottsdale, AZ United States
  Connect »

Sandip Patel, MD

Moores UC San Diego Cancer Center
La Jolla, CA United States
  Connect »

Anthony El-Khoueiry, MD

Norris Comprehensive Cancer Center, University of Southern California
Los Angeles, CA United States
  Connect »

Surasak Phuphanich, MD

Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center
Los Angeles, CA United States
  Connect »

Karen Kelly, MD

UC Davis Comprehensive Cancer Center
Sacramento, CA United States
  Connect »

Nicholas A Butowski, MD

University of California, San Francisco
San Francisco, CA United States
  Connect »

Kamalesh K. Sankhala, MD

Sarcoma Oncology Research Center
Santa Monica, CA United States
  Connect »

Zev A. Wainberg, MD

UCLA Hematology/Oncology- Santa Monica
Santa Monica, CA United States
  Connect »

Jose Lutzsky, MD

Mount Sinai Comprehensive Cancer Center
Miami Beach, FL United States
  Connect »

Heloisa Soares, MD,PhD

H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL United States
  Connect »

Bassel El-Rayes, MD

Emory University Hospital
Atlanta, GA United States
  Connect »

Nicklas Pfanzelter, MD

Rush University Medical Center
Chicago, IL United States
  Connect »

Jason J Luke, MD

University of Chicago Medical Center
Chicago, IL United States
  Connect »

Bert H. O'Neil, MD

Indiana University Health Hospital
Indianapolis, IN United States
  Connect »

Mohammed Milhem, MD

University of Iowa Hospitals and Clinics
Iowa City, IA United States
  Connect »

John T. Hamm, MD

Norton Cancer Institute, Norton Healthcare Pavilion
Louisville, KY United States
  Connect »

Julie Brahmer, MD

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD United States
  Connect »

Frank S. Hodi, MD

Dana Farber Cancer Institute
Boston, MA United States
  Connect »

Shirish Gadgeel, MD

Karmanos Cancer Institute
Detroit, MI United States
  Connect »

Ding Wang, MD, PhD

Henry Ford Hospital
Detroit, MI United States
  Connect »

Michaela L. Tsai, MD

Allina Health, Virginia Piper Cancer Institute
Minneapolis, MN United States
  Connect »

Mateusz Opyrchal, MD, PhD

Roswell Park Cancer Institute
Buffalo, NY United States
  Connect »

Mariza Daras, MD

Memorial Sloan Kettering
New York, NY United States
  Connect »

Philip D. Leming, MD

The Christ Hospital
Cincinnati, OH United States
  Connect »

Rachel Sanborn, MD

Providence Portland Medical Center
Portland, OR United States
  Connect »

Matthew Taylor, MD

Oregon Health and Science University
Portland, OR United States
  Connect »

Peter O'Dwyer, MD

Hospital of the University of Pennsylvania
Philadelphia, PA United States
  Connect »

Jennifer Johnson, MD

Thomas Jefferson University Hospital
Philadelphia, PA United States
  Connect »

James J. Lee, MD, PhD

University of Pittsburgh Cancer Institute, William M. Cooper Ambulatory Pavilion of the Hillman Cancer Center
Pittsburgh, PA United States
  Connect »

Carolyn Britten, MD

Hollings Cancer Center, Medical University of South Carolina
Charleston, SC United States
  Connect »

Emily Chan, MD

Henry-Joyce Cancer Clinic, Vanderbilt-Ingram Cancer Center,
Nashville, TN United States
  Connect »

Karen Fink, MD, PhD

Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center
Dallas, TX United States
  Connect »

Muhammad S Beg, MD

University of Texas Southwestern Medical Center
Dallas, TX United States
  Connect »

Jay-Jiguang Zhu, MD

Mischer Neuroscience Associates, The University of Texas Health Science Center at Houston
Houston, TX United States
  Connect »

Sarina A. Piha-Paul, MD

The University of Texas MD Anderson Cancer Center
Houston, TX United States
  Connect »

Andrew Brenner, MD

Cancer Therapy & Research Center, University of Texas Health Science Center at San Antonio
San Antonio, TX United States
  Connect »

Drew W Rasco, MD

South Texas Accelerated Research Therapeutics, LLC
San Antonio, TX United States
  Connect »

Sunil Sharma, MD

Huntsman Cancer Institute
Salt Lake City, UT United States
  Connect »

John Thompson, MD

Seattle Cancer Care Alliance
Seattle, WA United States
  Connect »